Results 391 to 400 of about 407,965 (429)
Some of the next articles are maybe not open access.

Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.

European Heart Journal, 2018
AIMS This study aims to examine the temporal trends and outcomes in patients who undergo percutaneous coronary intervention (PCI) with a previous or current diagnosis of cancer, according to cancer type and the presence of metastases.
Jessica Potts   +10 more
semanticscholar   +1 more source

Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention

Arteriosclerosis, Thrombosis and Vascular Biology, 2019
Current guidelines recommend dual antiplatelet therapy—a P2Y12 inhibitor (clopidogrel, prasugrel, or ticagrelor) and aspirin—for patients undergoing percutaneous coronary intervention. Although clopidogrel is the most commonly prescribed P2Y12 inhibitor,
Melissa D. Klein   +3 more
semanticscholar   +1 more source

Percutaneous coronary interventions in acute coronary syndromes

2015
Three different guidelines of the European Society of Cardiology cover the field of percutaneous coronary interventions. Their main recommendations are the following:All patients with an ST-segment elevation myocardial infarction should undergo immediate coronary angiography and percutaneous coronary intervention as soon as possible after the first ...
Viktor Kočka   +4 more
openaire   +1 more source

Percutaneous coronary intervention

Medicine, 2022
Sohail Q. Khan, P. Ludman
semanticscholar   +1 more source

Radiation and percutaneous coronary intervention

2010
Fluoroscopic procedures comprise a major component of the range of diagnostic and therapeutic measures available to the cardiologist. In contemporary practice, coronary angiography and percutaneous coronary intervention (PCI) are performed increasingly frequently.
Gurbir Bhatia, James Nolan
openaire   +1 more source

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

The Lancet, 2013
Friedrich W. Mohr   +12 more
semanticscholar   +1 more source

Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention.

Journal of the American College of Cardiology, 2020
Mahesh V. Madhavan   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy